R-azasetron besylate - Sensorion

Drug Profile

R-azasetron besylate - Sensorion

Alternative Names: R-azasetron besylate; SENS 401

Latest Information Update: 05 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sensorion
  • Developer Sensorion; Simbec Research
  • Class Heterocyclic bicyclo compounds; Oxazines; Small molecules; Vestibular disorder therapies
  • Mechanism of Action Calcineurin inhibitors; Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Sensorineural hearing loss; Hearing loss
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Sensorineural hearing loss
  • Preclinical Hearing loss

Most Recent Events

  • 27 Jul 2018 Sensorion plans the AUDIBLE-S phase II/III trial for Hearing Loss in October 2018 (NCT03603314)
  • 29 Jun 2018 Preclinical development for Hearing loss (Prevention in cochlear implant surgery) in France prior to June 2018
  • 29 Jun 2018 Adverse events data from a phase I trial in Sensorineural hearing loss (In volunteers) released by Sensorion
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top